The Bayer GroupBayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed 118,900 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion.

Bayer RSS Channel

Display # 
Title Published Date
Bayer's new five-year-contraceptive submitted for EU and US marketing authorization 20 November 2015
Bayer aligns organization with Life Science businesses 18 September 2015
New scholarships worth EUR 332,000 awarded by Bayer Foundation to promote international talents 16 September 2015
Bayer significantly improves earnings 29 July 2015
Bayer to divest Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million 10 June 2015
Xarelto® approved in China across three indications in the area of venous and arterial thromboembolism 07 May 2015
Strong start to the year for Bayer 30 April 2015
Bayer aspires to significantly expand Life Science businesses 11 March 2015
Bayer forms collaboration with academic and governmental institutions for Rivaroxaban study 10 February 2015
Bayer operationally strong - strategic focus on Life Science businesses 02 November 2014
Bayer supports World Thrombosis Day as founding global partner 13 October 2014
Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion 01 October 2014
Safety and sustained benefits of Adempas® from Bayer confirmed by results of long-term studies 08 September 2014
Bayer continues positive business development 30 July 2014
Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment 02 June 2014
Bayer HealthCare extends access to clinical trial data 13 May 2014
Bayer: Very successful start to 2014 29 April 2014
Bayer HealthCare to significantly increase production capacity in China 31 March 2014
Bayer to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development 18 March 2014
Bayer and Peking University establish new research center for translational research and drug discovery in Beijing 08 January 2014

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]